Correlation Between Moleculin Biotech and AEZS Old

Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and AEZS Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and AEZS Old into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Moleculin Biotech and AEZS Old, you can compare the effects of market volatilities on Moleculin Biotech and AEZS Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of AEZS Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and AEZS Old.

Diversification Opportunities for Moleculin Biotech and AEZS Old

0.0

Correlation Coefficient

Moleculin Biotech  AEZS Old

Pay attention - limited upside

The 3 months correlation between Moleculin and AEZS is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and AEZS Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AEZS Old and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with AEZS Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AEZS Old has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and AEZS Old go up and down completely randomly.

Pair Corralation between Moleculin Biotech and AEZS Old

If you would invest  523.00  in Moleculin Biotech on December 5, 2024 and sell it today you would lose (415.00) from holding Moleculin Biotech or give up 79.35% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Moleculin Biotech  vs.  AEZS Old

Moleculin Biotech

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Moleculin Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Moleculin Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

AEZS Old

Risk-Adjusted Performance

Very Weak

Over the last 90 days AEZS Old has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, AEZS Old is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Moleculin Biotech and AEZS Old

The main advantage of trading using opposite Moleculin Biotech and AEZS Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, AEZS Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AEZS Old will offset losses from the drop in AEZS Old's long position.

The idea behind Moleculin Biotech and AEZS Old pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.